Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2359631 | 0.81 | TP53 (0.36) | CYP3A4TDP1TP53TSHRHTR1A | |
| SCHEMBL17190352 | 0.81 | SIGMAR1 (0.43) | CYP3A4TSHRALDH1A1CHRM2HTR1A | |
| SCHEMBL4816081 | 0.80 | CYP3A4 (0.39) | CYP3A4TDP1KCNN4TP53TSHR | |
| SCHEMBL19530997 | 0.79 | CYP3A4 (0.43) | CYP3A4TDP1AOC3ESR1ESR2 | |
| SCHEMBL11727815 | 0.78 | TDP1 (0.38) | CYP3A4TDP1KCNN4TP53TSHR | |
| Hydrochloric Acid SCHEMBL16431629 | 0.78 | TDP1 (0.38) | CYP3A4TDP1KCNN4TP53TSHR | |
| SCHEMBL17598759 | 0.78 | TDP1 (0.43) | TDP1CHRM2HTR1AADRA2ACHRM1 | |
| SCHEMBL17930135 | 0.78 | SIGMAR1 (0.49) | CYP3A4ALDH1A1CHRM2HTR1AADRA2A | |
| SCHEMBL32681137 | 0.75 | AOC3 (0.40) | CYP3A4TDP1ALDH1A1SLC6A2SLC6A4 | |
| SCHEMBL17190349 | 0.75 | TAAR1 (0.45) | TSHRALDH1A1CHRM2ADRA2ACHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3044193-B1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2019-06-05 | — | — | EP | claimed |
| EP-3044193-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2016-07-20 | — | — | EP | claimed |
| WO-2015038377-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-19 | — | — | WO | claimed |
| US-20150073182-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-12 | — | — | US | claimed |
| US-20260061408-A1 | CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-03-05 | — | — | US | disclosed |
| EP-3044193-B1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-9566577-B1 | Catalytic hydrogenation using complexes of base metals with tridentate ligands | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2017-02-14 | — | — | US | disclosed |
| US-9434666-B2 | Catalytic hydrogenation using complexes of base metals with tridentate ligands | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2016-09-06 | — | — | US | disclosed |
| EP-3044193-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2016-07-20 | — | — | EP | disclosed |
| US-20150336862-A1 | CATALYTIC HYDROGENATION USING COMPLEXES OF BASE METALS WITH TRIDENTATE LIGANDS | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2015-11-26 | — | — | US | disclosed |
| WO-2015038377-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-19 | — | — | WO | disclosed |
| WO-2015038390-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-19 | — | — | WO | disclosed |
| US-20150073183-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-12 | — | — | US | disclosed |
| US-20150073182-A1 | PRODUCTION OF OLEFINS FROM A METHANE CONVERSION PROCESS | UOP LLC (US) | 2015-03-12 | — | — | US | disclosed |
| US-5037997-A | Method of preparing 1-butene and/or hexenes | INSTITUT KHIMICHESKOI FIZIKI AN SSSR (SU) | 1991-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260061408-A1 | CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION | CHRND, C5, SCO2 | CYP3A4 1662/4885TDP1 445/4885KCNN4 2761/4885 |
| US-20150336862-A1 | CATALYTIC HYDROGENATION USING COMPLEXES OF BASE METALS WITH TRIDENTATE LIGANDS | HRH4, HRH3, CHD4 | CYP3A4 683/4885TDP1 801/4885KCNN4 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.